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The levels of protein carboxyl methyltransferase, an enzyme that methylates free carboxyl groups of proteins, were de- 
termined in normal human proliferative and secretory endometrium and in poorly and well-differentiated endometrial 
carcinoma. Protein carboxyl methyltransferase activity was 67% higher in the well-differentiated carcinoma than in the 
normal tissues, while similar enzyme levels were observed in the two normal tissues and in the poorly differentiated carci- 
noma. The results suggest hat in the well-differentiated tumor there is excessive protein methylation and offer a possible 
biochemical probe for distinguishing between the two types of tumor. 
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1. INTRODUCTION 
Well-differentiated endometrial carcinomas, in 
contrast to poorly differentiated tumors, are usual- 
ly confined to the uterus at the time of diagnosis, 
and are therefore curable by total abdominal 
hysterectomy and bilateral salpingo-oophorectomy 
[ 11. The morphological determination of the grade 
of tumor differentiation is therefore an important 
prognostic factor in endometrial carcinoma. 
Recently biochemical methods, such as estrogen 
and progesterone [2] receptor-binding assays, were 
successfully used to assist in the distinction be- 
tween well- and poorly differentiated tumors, and 
in the proper management of endometrial car- 
cinoma. The determinaticm of tumor-associated 
biochemical changes is therefore important for the 
prognosis as well as for the understanding of 
tumor growth and differentiation. 
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Studies on tumor cell lines such as pituitary 
mouse tumor AT-t-20 [3], mouse Cl300 
neuroblastoma [4] and its clone NlE-115 [5] 
revealed that these cells contain the active protein 
carboxyl methyltransferase (PCM), an enzyme 
that post-translationally modifies free carboxyl 
groups of proteins [a]. Moreover, in the NlE-115 
cells it was found that PCM activity is increased 
under conditions that promote morphological dif- 
ferentiation [5]. These findings led us to consider 
the possibility that the PCM activity of en- 
dometrial carcinoma might differ from that found 
in the normal endometrium. We therefore examin- 
ed the activity of this enzyme in poorly and well- 
differentiated tumors as well as in normal en- 
dometrium. 
2. EXPERIMENTAL 
Endometrial tissues were obtained from 10 patients with en- 
dometrial carcinoma and from 14 patients with benign 
leiomyomata, all of whom underwent abdominal hysterectomy. 
Four of the endometrial carcinomas were morphologically 
characterized as poorly differentiated, and six as well- 
differentiated tumors. Of the 14 normal endometrial samples, 
six were in the proliferative phase and eight in the secretory 
phase. The uterus was opened immediately after extirpation and 
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endometrial samples obtained by scraping with a surgical knife 
were extensively washed with saline. In cases of endometrial 
carcinoma, the sample was scraped from the tumor itself. 
Tissues were blotted on filter paper, weighed and homogenized 
(IO%, w/v) in 5 mM Na phosphate buffer, pH 7.0, containing 
1 mM EDTA and 14 mM 2-mercaptoethanol with a motor- 
driven teflon-glass homogenizer. 
Usually lo-p1 aliquots of the whole tissue homogenate were 
used for the determination of PCM activity, employing the 
method of Diliberto et al. [6] and as detailed in [5]. Reaction 
mixtures (incubated for 10 min at 37°C) contained tissue 
homogenate, 20 mg/ml gelatin as methyl acceptor protein, 
2 CM S-[methyl-‘Hladenosyl-L-methionine ([3H]SAM, 15 Ci/ 
mmol, NEN) and 100 mM Na acetate buffer, pH 6.0. Each of 
the tissues were assayed in triplicate together with triplicate 
samples containing 100 pM S-adenosyl-L-homocystein, a com- 
petitive inhibitor of PCM. The latter served as blanks. 
3. RESULTS 
Mammalian PCMs have broad substrate 
specificity and can thus be determined using 
various exogenous methyl acceptor proteins [6]. In 
the present work the exogenous ubstrate used was 
gelatin, which is known to be an excellent methyl 
acceptor protein [7]. With a saturating concentra- 
tion of gelatin (20 mg/ml) and with 2 PM 
[3H]SAM as methyl donor, endometrial PCM ac- 
tivity varied linearly with time (for at least 12 min, 
fig. 1A) and with the amount of tissue homogenate 
(up to 1.25 mg tissue, fig.lB). 
In the initial experiments we determined the K,,, 
and V,,, values for PCM in normal endometrium 
and in endometrial carcinoma, using various con- 
centrations of [3H]SAM. The findings revealed no 
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significant differences in the K,,, for [3H]SAM be- 
tween the normal and malignant issues (Km = 7 + 
2 and 8 f 3 ,uM, respectively; n = 4, see fig.2). 
However, the Max appeared to be higher in the en- 
dometrial carcinoma. Since the Km values were 
similar, all subsequent experiments were per- 
formed under standard assay conditions with 2 PM 
[3H]SAM, 20 mg/ml of gelatin and 1 mg tissue. 
Fig.3A summarizes the results of the ex- 
periments performed with homogenates of normal 
endometrium (14 subjects) and of endometrial car- 
cinoma (10 subjects). The mean level of PCM ac- 
tivity in the endometrial carcinoma (92 f 
22 pm01 -min-’ . g tissue-‘) was significantly 
higher than that in the normal endometrial samples 
(62 f 19 pmol - min-’ . g tissue-‘) as analyzed by 
the Mann Whitney U test 0) < 0.005). Comparison 
of the means of the four groups of endometrial 
tissues (proliferative endometrium, secretory en- 
dometrium, poorly differentiated and well- 
differentiated carcinoma) by analysis of variance 
(ANOVA) yielded the value F = 6.13, p < 0.005. 
This indicated that at least two of the four in- 
dividual groups differ significantly from one 
another. The differences between the means of the 
individual groups were then analyzed by the Mann 
Whitney U test. No difference was observed be- 
tween the mean PCM activities of the secretory (n 
= 5) and the proliferative (n = 9) endometrial 
samples (64 f 11 and 60 f 21 pmol.min-‘*g-l, 
respectively, p = 0.64). However, a significant dif- 
ference in mean PCM activity was found between 
the well-differentiated carcinoma (103 f 
0.5 1 
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Fig. 1. Linearity of PCM activity as a function of time (A) and the amount of tissue (B). Enzyme activity was determined as described 
in section 2, using 2 PM [‘HISAM, 20 mg/ml of gelatin, and homogenate quivalent o either 1 mg tissue (A) or 0.25-l .25 mg tissue 
(B). Data are expressed in pmol [‘HImethyl groups transferred to the gelatin per g tissue (A) or per 10 min (B). 
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Fig.2. Eadie-Hofstee plot of PCM activity in normal secretory 
endometrium and in well-differentiated endometrial carcinoma. 
Enzyme activity was determined as described in section 2. 
Results are expressed in pmol [3H]methyl groups transferred to 
gelatin/min per g tissue. 
22 pmol-min-‘*g-l, n = 6) and the normal tissues 
0, < 0.02), and between the well-differentiated and 
the poorly differentiated carcinomas (103 f 22 vs 
75 +- 11 pmol.min-‘*g-l, p < 0.05, see fig.3B). 
The mean PCM activity of the poorly differen- 
tiated carcinoma was not significantly different 
from that of either of the two normal tissues. 
4. DISCUSSION 
Methylation of proteins in eukaryotic cells has 
been associated with the control of cellular dif- 
ferentiation, as indicated by the observed elevation 
in levels of PCM activity during the differentiation 
of human monocytes and macrophages [8,9] and 
in the developing rat liver [lo]. Here, no difference 
in PCM activity was observed between the dif- 
ferentiated secretory endometrium and the pro- 
liferative tissue, possibly because the detection of 
such differences would necessitate a correlation 
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Fig.3. PCM activity in normal endometrium (14 subjects) and 
in endometrial carcinoma (10 subjects). Enzyme activity was 
determined in each case with 2 PM [‘HISAM, 20 mg/ml gelatin 
and 1 mg tissue. (A) Comparison between the normal and the 
malignant tissues. (B) Comparison between the poorly 
differentiated (p.d.) and the well differentiated (w.d.) 
carcinoma. Horizontal bar represents the mean values of PCM 
activity. Statistical analysis is described in the text. 
between PCM activity and the blood levels of 
estrogen and progesterone. However, comparison 
between the PCM activity in the malignant and the 
normal tissues revealed a 47% higher activity in the 
carcinoma (fig.3). The small difference in PCM ac- 
tivity between the poorly differentiated carcinoma 
and the normal tissues was not statistically signifi- 
cant, yet the 67% higher activity in the well- 
differentiated endometrial carcinoma than in the 
normal tissues was clearly significant. The PCM 
activity in the well-differentiated carcinoma was 
also significantly higher (by 37%) than in the poor- 
ly differentiated tumor. It thus appears that the 
high enzyme activity is primarily associated with 
the well-differentiated type of tumor. This finding 
may have important diagnostic as well as 
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prognostic implications. It is possible that the use REFERENCES 
of electrophoretic methods for the separation of 
PCM isozymes [l I] in combination with anti PCM 111 Eifel, P.J., Ross, J.C., Hendrickson, M.R., Cox. R.S.. 
antibodies will allow a better distinction between 
well and poorly differentiated tumors. 
Kempson, R.L. and Martinez, A. .(1983)-Cancer 52; 
1026-1031. 
The higher PCM activity in the well- 
differentiated endometrial carcinoma than in the 
poorly differentiated tumor is reminiscent of the 
observed increase in PCM activity of mouse 
neuroblastoma cells cultured under conditions that 
promote morphological differentiation [5]. It 
raises the possibility of an association between 
PCM activity and morphological differentiation of 
transformed cells. 
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